US-Listed China Biotech Shares Hit By Broad China Cybersecurity Review

Over-Valuation Correction As Well?

 
• By Brian Yang
  
US-LISTED CHINESE BIOTECHS FALL AMID SPREADING CYBERSECURITY REVIEWS • Source: Alamy

More from China

More from Focus On Asia